| CP150-50MG
| RecombiMAb mouse IgG2a (D265A) isotype control, anti-hen egg lysozyme
| 50 mg
| BioXCell
|
|
| Mouse
| Othe
| Solicitar Precio
| Solicitar
|
| BP0055-25MG
| InVivoPlus anti-mouse IFN?
| 25 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0063-25MG
| InVivoPlus anti-mouse GITR
| 25 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0267-1MG
| ReadyTag anti-OVA
| 1 mg
| BioXCell
| ELISA
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| CP149-50MG
| RecombiMAb human IgG1 (LALA-PG) isotype control, anti-hen egg lysozyme
| 50 mg
| BioXCell
|
|
| Human
| Othe
| Solicitar Precio
| Solicitar
|
| RT0265-25MG
| ReadyTag anti-GFP
| 25 mg
| BioXCell
| Western blot, Immunofluorescence
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0010-5MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 5 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP148-25MG
| RecombiMAb human IgG4 S228P L235E P329G (SPLEPG) isotype control, anti-hen egg lysozyme
| 25 mg
| BioXCell
|
|
| Human
| Othe
| Solicitar Precio
| Solicitar
|
| BP0239-25MG
| InVivoPlus anti-mouse CD137 (4-1BB)
| 25 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0086-100MG
| InVivoPlus mouse IgG2b isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| RT0263-5MG
| ReadyTag anti-c-myc
| 5 mg
| BioXCell
| Western blot, ELISA, Flow cytometry
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0014-25MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 25 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0003-5MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 5 mg
| BioXCell
| Blocking of PD-1/PD-L signaling; Flow Cytometry; I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0075-1-50MG
| InVivoPlus anti-mouse Ly6G
| 50 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0301-25MG
| InVivoPlus human IgG2 isotype control
| 25 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| BP0086-50MG
| InVivoPlus mouse IgG2b isotype control
| 50 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0099-100MG
| InVivoPlus recombinant CTLA-4-Ig (hum./hum.)
| 100 mg
| BioXCell
|
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| BP0033-2-50MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0290-25MG
| InVivoPlus rat IgG1 isotype control
| 25 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| SIM0004-25MG
| InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar)
| 25 mg
| BioXCell
| CTLA-4 neutralization; Flow Cytometry; ELISA; West
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| IPT065-50ML
| InVivoPure pH 6.5T Dilution Buffer
| 50 ml
| BioXCell
| N/A
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| BP0003-3-100MG
| InVivoPlus anti-mouse CD4
| 100 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0008-100MG
| InVivoSIM anti-human CD20 (Rituximab Biosimilar)
| 100 mg
| BioXCell
| Flow Cytometry; ELISA; Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0005-100MG
| InVivoSIM anti-human HER2 (Trastuzumab Biosimilar)
| 100 mg
| BioXCell
| Flow Cytometry; ELISA; Immunohistochemistry; Weste
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0066-100MG
| InVivoPlus anti-mouse Thy1.2 (CD90.2)
| 100 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0356-100MG
| InVivoPlus anti-mouse CD20
| 100 mg
| BioXCell
| in vivo B cell depletion, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0055-100MG
| InVivoPlus anti-mouse IFN?
| 100 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0329-100MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 100 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0091-25MG
| InVivoPlus polyclonal Armenian hamster IgG
| 25 mg
| BioXCell
|
|
| Armenian hamster
| N/
| Solicitar Precio
| Solicitar
|
| BP0004-1-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0283-25MG
| InVivoPlus anti-human/mouse/rat CD47
| 25 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Mouse
| human/mouse/rat
| Solicitar Precio
| Solicitar
|
| BP0063-100MG
| InVivoPlus anti-mouse GITR
| 100 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| CP146-50MG
| RecombiMAb anti-mouse CTLA-4 (CD152)
| 50 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0264-25MG
| ReadyTag anti-GST
| 25 mg
| BioXCell
| Western blot
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0131-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0239-5MG
| InVivoPlus anti-mouse CD137 (4-1BB)
| 5 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| CP150-5MG
| RecombiMAb mouse IgG2a (D265A) isotype control, anti-hen egg lysozyme
| 5 mg
| BioXCell
|
|
| Mouse
| Othe
| Solicitar Precio
| Solicitar
|
| BP0036-100MG
| InVivoPlus anti-mouse NK1.1
| 100 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0267-5MG
| ReadyTag anti-OVA
| 5 mg
| BioXCell
| ELISA
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| RT0268-5MG
| ReadyTag anti-HA
| 5 mg
| BioXCell
| ELISA, Western blot, Immunoprecipitation, Immunofl
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0051-5MG
| InVivoPlus anti-mouse IL-12 p40
| 5 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0301-5MG
| InVivoPlus human IgG2 isotype control
| 5 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| BP0329-5MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 5 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0012-1MG
| InVivoSIM anti-human VEGFR-2 (Ramucirumab Biosimilar)
| 1 mg
| BioXCell
| Functional assays, Immunohistochemistry, Flow cyto
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0031-5MG
| InVivoPlus anti-mouse OX40 (CD134)
| 5 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0087-25MG
| InVivoPlus polyclonal Syrian hamster IgG
| 25 mg
| BioXCell
|
|
| Syrian hamster
| N/
| Solicitar Precio
| Solicitar
|
| BP0175-5MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 5 mg
| BioXCell
| in vivo depletion of CD71+ cells
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0001-50MG
| InVivoSIM anti-human TNF? (Adalimumab Biosimilar)
| 50 mg
| BioXCell
| TNF? neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0061-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0101-50MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 50 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|